Metropolitan Life Insurance CO Shattuck Labs, Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$8.36 - $21.08 $70,040 - $176,608	-8,378 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$17.57 - $28.95 $147,201 - $242,543	8,378 New	8,378 $170,000
Q2 2021 Mar 30, 2023	BUY	$24.14 - $37.68 $97,911 - $152,830	4,056 Added 93.85%	8,378 $242,000
Q2 2021 Aug 16, 2021	BUY	$24.14 - $37.68 $202,148 - $315,532	8,374 Added 209350.0%	8,378 $243,000
Q1 2021 Jun 26, 2023	BUY	$27.92 - $52.5 $120,670 - $226,905	4,322 New	4,322 $126 Million
Q1 2021 May 14, 2021	SELL	$27.92 - $52.5 $120,558 - $226,695	-4,318 Reduced 99.91%	4 $126,000
Q4 2020 Jun 22, 2023	BUY	$19.0 - $57.61 $82,118 - $248,990	4,322 New	4,322 $226,000
Q4 2020 Mar 30, 2023	BUY	$19.0 - $57.61 $82,118 - $248,990	4,322 New	4,322 $226,000
Q4 2020 Feb 16, 2021	BUY	$19.0 - $57.61 $82,118 - $248,990	4,322 New	4,322 $227,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.